← Every company

Ligand Pharmaceuticals Inc SEC Filings

What Ligand Pharmaceuticals Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.

LGND overview →
Filings on file
156
since Nov 3, 2016
Warning signs
3
latest Apr 13, 2018
Last results
Aug 6, 2026
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834

Newest first

Each label is a form type or an 8-K item as filed; each row links to the filing.

FiledWhat it reportsDocument
Aug 7, 2026
Quarterly report
10-Q
Read ↗
Aug 6, 2026
Results announced
8-K
Read ↗
Jul 14, 2026
Acquisition or sale completedMaterial agreementNew debt
8-K
Read ↗
Jun 25, 2026
Material agreementNew debtUnregistered share sale
8-K
Read ↗
Jun 22, 2026
Material agreement
8-K
Read ↗
Jun 9, 2026
Executive or director changeShareholder vote
8-K
Read ↗
May 18, 2026
Material agreement
8-K
Read ↗
May 8, 2026
Quarterly report
10-Q
Read ↗
May 7, 2026
Results announced
8-K
Read ↗
Apr 30, 2026
Material agreement
8-K
Read ↗
Apr 27, 2026
Material agreement
8-K
Read ↗
Feb 27, 2026
Annual report
10-K
Read ↗
Feb 26, 2026
Results announced
8-K
Read ↗
Nov 7, 2025
Quarterly report
10-Q
Read ↗
Nov 6, 2025
Results announced
8-K
Read ↗
Sep 16, 2025
Material agreementNew debt
8-K
Read ↗
Aug 14, 2025
Material agreementNew debtUnregistered share sale
8-K
Read ↗
Aug 11, 2025
Material agreement
8-K
Read ↗
Aug 8, 2025
Quarterly report
10-Q
Read ↗
Aug 7, 2025
Results announced
8-K
Read ↗
Jun 9, 2025
Shareholder vote
8-K
Read ↗
May 9, 2025
Quarterly report
10-Q
Read ↗
May 8, 2025
Results announced
8-K
Read ↗
Feb 28, 2025
Annual report
10-K
Read ↗
Feb 27, 2025
Results announced
8-K
Read ↗
Feb 25, 2025
Material agreement
8-K
Read ↗
Nov 8, 2024
Quarterly report
10-Q
Read ↗
Nov 7, 2024
Results announced
8-K
Read ↗
Aug 7, 2024
Quarterly report
10-Q
Read ↗
Aug 6, 2024
Results announced
8-K
Read ↗
Aug 2, 2024
Executive or director change
8-K
Read ↗
Jul 17, 2024
Acquisition or sale completed
8-K
Read ↗
Jul 10, 2024
Material agreementNew debt
8-K
Read ↗
Jul 8, 2024
Material agreement
8-K
Read ↗
Jun 17, 2024
Executive or director changeShareholder vote
8-K
Read ↗
May 8, 2024
Quarterly report
10-Q
Read ↗
May 7, 2024
Results announced
8-K
Read ↗
May 7, 2024
Material agreement
8-K
Read ↗
Feb 29, 2024
Annual report
10-K
Read ↗
Feb 27, 2024
Results announced
8-K
Read ↗
Dec 1, 2023
Material agreement
8-K
Read ↗
Nov 13, 2023
Results announced
8-K/A
Read ↗
Nov 9, 2023
Quarterly report
10-Q
Read ↗
Nov 8, 2023
Results announced
8-K
Read ↗
Oct 18, 2023
Acquisition or sale completedMaterial agreement
8-K
Read ↗
Sep 27, 2023
Executive or director change
8-K
Read ↗
Aug 9, 2023
Quarterly report
10-Q
Read ↗
Aug 8, 2023
Results announced
8-K
Read ↗
Jun 9, 2023
Shareholder vote
8-K
Read ↗
May 8, 2023
Quarterly report
10-Q
Read ↗
May 4, 2023
Results announced
8-K
Read ↗
Feb 28, 2023
Annual report
10-K
Read ↗
Feb 22, 2023
Results announced
8-K
Read ↗
Dec 14, 2022
Executive or director change
8-K
Read ↗
Dec 5, 2022
Executive or director change
8-K
Read ↗
Nov 8, 2022
Quarterly report
10-Q
Read ↗
Nov 7, 2022
Results announced
8-K
Read ↗
Nov 4, 2022
Executive or director changeAcquisition or sale completedMaterial agreement
8-K
Read ↗
Sep 30, 2022
Material agreement
8-K
Read ↗
Aug 9, 2022
Quarterly report
10-Q
Read ↗
Aug 8, 2022
Results announced
8-K
Read ↗
Aug 2, 2022
Executive or director change
8-K
Read ↗
Jun 29, 2022
Executive or director change
8-K
Read ↗
Jun 13, 2022
Executive or director changeShareholder vote
8-K
Read ↗
May 9, 2022
Quarterly report
10-Q
Read ↗
May 4, 2022
Results announced
8-K
Read ↗
Mar 24, 2022
Material agreement
8-K
Read ↗
Feb 28, 2022
Annual report
10-K
Read ↗
Feb 17, 2022
Results announced
8-K
Read ↗
Jan 27, 2022
Executive or director change
8-K
Read ↗
Jan 14, 2022
Material agreement
8-K
Read ↗
Nov 9, 2021
Quarterly report
10-Q
Read ↗
Nov 9, 2021
Results announced
8-K
Read ↗
Aug 3, 2021
Quarterly report
10-Q
Read ↗
Jul 29, 2021
Results announced
8-K
Read ↗
Jul 14, 2021
Executive or director change
8-K
Read ↗
Jun 7, 2021
Shareholder vote
8-K
Read ↗
May 6, 2021
Quarterly report
10-Q
Read ↗
May 3, 2021
Results announced
8-K
Read ↗
Feb 24, 2021
Annual report
10-K
Read ↗
Feb 3, 2021
Results announced
8-K
Read ↗
Jan 28, 2021
Executive or director changeMaterial agreement
8-K
Read ↗
Dec 16, 2020
Executive or director changeShareholder vote
8-K
Read ↗
Nov 6, 2020
Quarterly report
10-Q
Read ↗
Oct 30, 2020
Results announced
8-K
Read ↗
Oct 20, 2020
Results announced
8-K
Read ↗
Oct 13, 2020
Material agreement
8-K
Read ↗
Oct 1, 2020
Acquisition or sale completedMaterial agreement
8-K
Read ↗
Sep 23, 2020
Material agreement
8-K
Read ↗
Sep 10, 2020
Material agreement
8-K
Read ↗
Aug 31, 2020
Tender offer
SC TO-T
Read ↗
Aug 11, 2020
Material agreement
8-K
Read ↗
Aug 7, 2020
Quarterly report
10-Q
Read ↗
Aug 3, 2020
Results announced
8-K
Read ↗
Jun 11, 2020
Shareholder vote
8-K
Read ↗
May 8, 2020
Quarterly report
10-Q
Read ↗
May 6, 2020
Results announced
8-K
Read ↗
Apr 7, 2020
Material agreement
8-K
Read ↗
Apr 6, 2020
Results announced
8-K
Read ↗
Feb 27, 2020
Annual report
10-K
Read ↗
Feb 11, 2020
Material agreement
8-K
Read ↗
Feb 6, 2020
Results announced
8-K
Read ↗
Dec 23, 2019
Executive or director change
8-K
Read ↗
Nov 8, 2019
Quarterly report
10-Q
Read ↗
Nov 5, 2019
Results announced
8-K
Read ↗
Oct 16, 2019
Executive or director change
8-K
Read ↗
Aug 8, 2019
Quarterly report
10-Q
Read ↗
Jul 30, 2019
Results announced
8-K
Read ↗
Jun 10, 2019
Executive or director changeShareholder vote
8-K
Read ↗
May 24, 2019
Material agreement
8-K
Read ↗
May 9, 2019
Quarterly report
10-Q
Read ↗
May 2, 2019
Results announced
8-K
Read ↗
Mar 6, 2019
Acquisition or sale completed
8-K
Read ↗
Mar 5, 2019
Material agreement
8-K
Read ↗
Feb 28, 2019
Annual report
10-K
Read ↗
Feb 7, 2019
Results announced
8-K
Read ↗
Jan 25, 2019
Executive or director change
8-K
Read ↗
Dec 18, 2018
Material agreement
8-K
Read ↗
Nov 8, 2018
Quarterly report
10-Q
Read ↗
Nov 8, 2018
Results announced
8-K
Read ↗
Oct 10, 2018
Acquisition or sale completed
8-K
Read ↗
Aug 9, 2018
Material agreement
8-K
Read ↗
Aug 8, 2018
Quarterly report
10-Q
Read ↗
Aug 6, 2018
Results announced
8-K
Read ↗
Jun 27, 2018
Material agreement
8-K
Read ↗
Jun 19, 2018
Shareholder vote
8-K
Read ↗
May 22, 2018
Material agreementNew debtUnregistered share sale
8-K
Read ↗
May 9, 2018
Quarterly report
10-Q
Read ↗
May 8, 2018
Results announced
8-K
Read ↗
Apr 13, 2018
Debt accelerated
8-K
Read ↗
Mar 22, 2018
Material agreement
8-K
Read ↗
Mar 7, 2018
Material agreement
8-K/A
Read ↗
Mar 6, 2018
Material agreement
8-K
Read ↗
Mar 1, 2018
Annual report
10-K
Read ↗
Feb 21, 2018
Results announced
8-K
Read ↗
Jan 29, 2018
Executive or director change
8-K
Read ↗
Nov 9, 2017
Quarterly report
10-Q
Read ↗
Nov 9, 2017
Results announced
8-K
Read ↗
Nov 2, 2017
Quarterly report
10-Q/A
Read ↗
Oct 4, 2017
Material agreement
8-K
Read ↗
Aug 21, 2017
Executive or director change
8-K
Read ↗
Aug 9, 2017
Quarterly report
10-Q
Read ↗
Jun 1, 2017
Material agreement
8-K
Read ↗
May 26, 2017
Shareholder vote
8-K
Read ↗
May 9, 2017
Quarterly report
10-Q
Read ↗
May 9, 2017
Results announced
8-K
Read ↗
Feb 28, 2017
Annual report
10-K
Read ↗
Feb 23, 2017
Results announced
8-K
Read ↗
Jan 27, 2017
Executive or director change
8-K
Read ↗
Nov 14, 2016
Quarterly report
10-Q
Read ↗
Nov 14, 2016
Quarterly report
10-Q/A
Read ↗
Nov 14, 2016
Quarterly report
10-Q/A
Read ↗
Nov 14, 2016
Annual report
10-K/A
Read ↗
Nov 14, 2016
Earlier accounts withdrawnResults announced
8-K
Read ↗
Nov 9, 2016
Late filing notice
NT 10-Q
Read ↗
Nov 3, 2016
Results announced
8-K
Read ↗

Source: Ligand Pharmaceuticals Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.

More on LGND

Related datasets